A comprehensive analysis of bromodomain-containing proteins across cancer types reinforces this heterogeneity, showing that distinct BET genes are differentially expressed in specific tumor lineages (49).This lineage- and cell state-dependence requires a mechanistic and context-specific understanding of BET protein function for successful BET-targeted therapies in the clinic (6). This evidence concerns the gene DNER and neoplasm.